Customer Care Tel: 0161 483 5884
Email: ukcustomer@alere.com
Website: www.alere.co.uk
Connecting withSexual Health
Evaluation of Determine® HIV - 1/2 Ag/Ab Combo
Jane Newman, Senior BMS, HPA Southampton, Virology Department
A range of samples from patients previously tested either for HIV-1/2 Ag/Ab via Architect platform or for HIV-1 Viral Load via Roche, were re-tested using the Determine® HIV-1/2 Ag/Ab Combo. These samples made up six panels, and included:
1. High positive viral load sample (>10,000)
2. Low positive viral load samples from patients NOT on treatment
3. Positive sample with high Architect values (>300 vs. Dynamic range of 0-800)
4. Positive samples with low Architect values (<100)
5. Patient samples tested negative by Architect HIV-1/2 Ag/Ab screen
6. A range of samples from suspected seroconversion patients
Read full article
-
Alere Determine™ HIV 1/2 Ag/Ab Combo
A breakthrough, fourth generation, rapid in vitro immunoassay for the qualitative detection of HIV p24 antigen and antibodies to HIV-1 and HIV-2 in serum, plasma and whole blood. Read more
![Image of Alere Determine[tm] HIV 1/2 Ag/Ab Combo](/images/product/thumbs/0_prod_1e588d8c83edcc2475b13c45a0223cc1.jpg)